首页|粪便mSDC2检测在体检人群结直肠肿瘤筛查中的应用价值

粪便mSDC2检测在体检人群结直肠肿瘤筛查中的应用价值

扫码查看
目的 分析粪便多配体聚糖 2 基因甲基化(mSDC2)检测在结直肠肿瘤(CN)中的筛查结果,评估其在体检人群CN筛查中的潜力和价值。方法 回顾性分析2021年 3 月至 2022 年7月在北京大学深圳医院健康管理中心接受mSDC2 检测并完成肠镜检查的患者,以mSDC2 检测作为初筛方法,以肠镜检查与病理结果为金标准,分析筛查结果。结果 共 323 例患者接受mSDC2 检测并完成肠镜检查,不同性别、年龄段患者的mSDC2检测结果比较,差异无统计学意义(P>0。05)。mSDC2检测结果阳性88例,灰度区68 例,阴性167例。323例受检者中,结直肠癌 4例、进展期腺瘤(AA)29 例、非进展期腺瘤(NAA)63 例、非腺瘤性息肉(NAP)54例、其他173例(包括肠道正常9例、肠炎或/和憩室 163 例、黑变病1 例);mSDC2 对结直肠癌的相对敏感性为100。00%,对AA的相对敏感性为62。07%。mSDC2阳性中,结直肠癌和AA的检出率分别为4。55%和20。45%。阳性、灰度区与阴性的结直肠癌和AA检出率比较,差异具有统计学意义(P<0。05);阳性、灰度区、阴性的NAA、NAP检出率无显著差异(P>0。05)。在CN中,mSDC2 阳性、灰度区、阴性的病变检出率比较,差异具有统计学意义(P<0。05);在全部肠道病变中,mSDC2 阳性、灰度区、阴性的病变检出率比较,差异具有统计学意义(P<0。05)。结论 粪便mSDC2检测作为初筛方法,显著提高了肠镜检查的病变检出率,可以作为体检人群CN早期筛查的优选策略。
Application value of fecal mSDC2 detection in colorectal neoplasms screening in physical examination population
Objective To analyze the screening results of methylated syndecan-2(mSDC2)detection in colorectal neoplasms(CN),and to evaluate its potential and value in CN screening in physical examination population.Methods The patients who received mSDC2 detection and completed colonoscopy in the health management center of Peking University Shenzhen Hospital from March 2021 to July 2022 were retrospectively analyzed.The mSDC2 detection was used as the primary screening method,and the colonoscopy and pathological results were used as the gold standard to analyze the screening results.Results A total of 323 patients received mSDC2 test and completed colonoscopy,there was no significant difference in mSDC2 test results between patients of different genders and age groups(P>0.05).The results of mSDC2 test were positive in 88 cases,gray area in 68 cases,and negative in 167 cases.Among the 323 subjects,there were 4 cases of colorectal cancer,29 cases of advanced adenoma(AA),63 cases of non-advanced adenoma(NAA),54 cases of non-adenomatous polyp(NAP)and 173 other cases(including 9 cases of normal intestine,163 cases of enteritis or/and diverticulum,and 1 case of melanosis);the relative sensitivity of mSDC2 to colorectal cancer was 100.00%,and the relative sensitivity to AA was 62.07%.The detection rates of colorectal cancer and AA in mSDC2 positive were 4.55%and 20.45%,respectively.There was statistically significant difference in the detection rates of colorectal cancer and AA among positive,gray area and negative(P<0.05);there was no significant difference in the detection rate of NAA and NAP among positive,gray area and negative(P>0.05).In CN,the detection rate of mSDC2 positive,gray area and negative was statistically significant(P<0.05);in all intestinal lesions,the detection rate of mSDC2 positive,gray area and negative was statistically significant(P<0.05).Conclusion As a preliminary screening method,the detection of fecal mSDC2 significantly improves the detection rate of lesions in colonoscopy,and can be used as a preferred strategy for early screening of CN in physical examination population.

methylated syndecan-2colorectal neoplasmsfeces

陈晓红、杨林、张永建、钟倩倩、蔡永江

展开 >

北京大学深圳医院健康管理中心,广东 深圳,518036

多配体聚糖2基因甲基化 结直肠肿瘤 粪便

2024

临床医学研究与实践

临床医学研究与实践

ISSN:
年,卷(期):2024.9(14)
  • 17